Frontlight ResearchEarly access
Trial site
Five Towns Neuroscience Research
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Epilepsy6 trials
- Multiple sclerosis1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Biohaven Therapeutics Ltd.2 trials
- SK Life Science, Inc.2 trials
- Xenon Pharmaceuticals Inc.2 trials
- Novartis Pharmaceuticals1 trial
Running trials
Enrolling by invitation
Active, not recruiting
Active, not recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy1 recruiting
Closed trials
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026